Get all your news in one place.

100’s of premium titles.
One app.

Start reading

Get all your news in one place.

100’s of premium titles. One news app.

Start reading

The Latest Breaking News from Covid-19

Novavax strikes $1.2 billion deal with Sanofi in major turnaround

It's a major turnaround for a drug company that warned last year about its ability to stay in business.

Axios

French, US Drug Firms Team Up For Covid-flu Shot

French pharmaceutical giant Sanofi and struggling US rival Novavax announced Friday an alliance to sell a Covid vaccine and develop another that combines with a flu shot.

International Business Times

FLiRT Covid variant: What we know about strain that is spreading in UK

Doctors have issued a warning as UKHSA data shows a rise in British cases of the virus

Evening Standard

From analysis to the latest developments in health,
read the most diverse news in one place.

Covishield side effects | Doctors’ group urges Centre to review all COVID vaccines

Doctors express concern over Covishield vaccine safety due to potential blood clot side effects, urging government review and action.

The Hindu

Lack Of Women's Rights Exposed In Iceland As It Tops WEF's Gender Gap Index 14 Years In A Row

Concerns about gender equality in Iceland has significantly increased since reported acts of violence against women mounted during the Covid-19 pandemic.

International Business Times UK

US Online Retail Spending Increases By 7% In Jan-April

Discover the factors driving the 7% surge in online retail spending in the US, including demand for affordable products and the impact of COVID-19 restrict...

Top News

New mRNA vaccine for deadly brain cancer triggers a strong immune response

COVID-19 vaccine development paves way to a new class of cancer immunotherapy.

LiveScience

Read news from The Economist, FT, and more,
with one subscription

Blue Ruin by Hari Kunzru review – art monsters

From the galleries and squats of 90s London to Covid-era New York, a tale of fame and fallout

The Guardian - UK

Bank Of England To Test Rate Cut Assumptions

Bank of England testing negative interest rates to assess impact on UK economy amidst COVID-19 challenges.

Top News

US Fuel Demand Hits Pandemic Lows, Affects Refining Margins

Learn how the COVID-19 pandemic has led to a significant drop in fuel demand in the US, impacting refining margins and requiring refineries to innovate and...

Top News

How much have fast-food prices gone up since 2020? Price hikes at 6 popular chains

Prices in general have gone up about 21.5% since COVID-19 struck, but fast-food price hikes have outpaced headline inflation by wild margins. Here's how much some of the most popular items at your favorite fast-food joints have gone up in price.

The Street

Uber Forecasts Lower-Than-Expected Gross Bookings For Second Quarter

Uber's Q2 gross bookings fall short of expectations due to COVID-19 impact, but company remains optimistic about future growth.

Top News

AstraZeneca withdraws Covid vaccine worldwide due to 'surplus'

The pharma giant says the decision was made due to the availability of superior vaccines

Evening Standard

AstraZeneca Withdraws Covid Vaccine As Demand Dives

Anglo-Swedish drugmaker AstraZeneca on Wednesday said it was withdrawing Covid vaccine Vaxzevria, one of the first produced in the deadly pandemic, citing "commercial reasons" following a slump in demand.

International Business Times

Get all your
news in one place.

100’s of premium titles.
One news app.

The Guardian - UK

Welsh first minister rejects Covid inquiry perjury claims

Vaughan Gething expresses regret over donations scandal amid anger over separate allegations about deleted messages

Top News

Japan Supports Boe With June Rate Cut

Japan supports Bank of England with potential rate cut amid COVID-19 economic uncertainty, reflecting international cooperation for global stability.

Dynamite News

AstraZeneca withdraws COVID-19 vaccine worldwide, cites commercial reasons

The pharmaceutical giant AstraZeneca's COVID-19 vaccine is being withdrawn worldwide after the company acknowledged for the first time in court documents that it can cause a rare and dangerous side effect, according to a report in the British Newspaper 'The Telegraph'. Read further on Dynamite News:

The Guardian - AU

AstraZeneca withdraws Covid-19 vaccine worldwide, citing surplus of newer vaccines

Pharmaceutical company says newer shots led to decline in demand for AstraZeneca vaccine, which is no longer being manufactured or supplied

Get all your
news in one place.

100’s of premium titles.
One news app.

AAP

Opioid treatment drug offers hope for long COVID cases

A drug that has been on the market to treat opioid addiction can potentially be used to alleviate debilitating illnesses like long COVID, researchers say.

The Guardian - AU

Victoria state budget 2024 winners and losers: $400 for school students, home buyer fund boost and increased levies

Government to expand shared-equity scheme for home buyers but will delay long-awaited airport train

The Hindu

Flexible office spaces reshape post-COVID work environments

COVID-19 has transformed India's office space landscape, leading to a surge in flexible office arrangements and hybrid work models.

Investors Business Daily

BioNTech Lifts As Covid Sales Plummet With 90% Of Revenue Still To Come

BioNTech stock lifted a fraction Monday after Covid vaccine sales dropped again in the first quarter, amid wide losses.

The Guardian - UK

Heineken to pump £39m into reopening and revamping UK pubs

Firm aims to upgrade 612 outlets and reopen 62 this year amid signs of rising consumer confidence

The Guardian - UK

Scientists create vaccine with potential to protect against future coronaviruses

Researchers say experimental shot is step towards goal of creating vaccines before a pandemic has started

Salon

Can we bridge the science-trust gap?

Partisan furor and COVID-19 highlighted a deadly distrust in science. But a leading scientist sees a path forward

1 … 52 53 54 55

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.